AbCellera surges on positive mid-stage results for menopause drug ABCL635
· seekingalpha.com
AbCellera (ABCL) stock jumps 35% after positive Phase 2 ABCL635 menopause hot flash data, showing strong symptom reductions vs placebo—read the update.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...